Jahnavi Ravindranath

Jun 19, 2024 | horsesforsources.com | Phil Fersht |Mayank Madhur |Jahnavi Ravindranath

There has been much progress with life expectancies, health outcomes, and access to care across the globe—although it is inconsistent. Therefore, it should be unsurprising that the triple aim of care (cost, experience, and health outcomes) remains elusive in the US and worldwide. Still, the post-pandemic years have seen significant progress in applying technologies smartly and an attitudinal shift to experiment in a regulated industry.